Page results
-
We are now administering new COVID-19 treatments for patients at highest risk in the community. The service can prescribe oral antivirals to be taken at home, and give intravenous antibody treatments at the hospital.
-
How we use your information at UCLH: what you need to know
-
The Hyperacute Stroke Unit (HASU) and the Transient Ischaemic Attack (TIA) services were relocated from the seventh floor of University College Hospital to The National Hospital for Neurology and Neurosurgery (NHNN) on 20 March 2020 as part of UCLH’s response to the Covid-19 pandemic.
-
A UCLH investment of £20 million will fund training for healthcare assistants and major new research facilities which will benefit patient care.
-
People with obesity whose weight and health improve following drug treatment are likely to need the treatment long term, according to a UCLH and UCL study.
-
Thrombotic Thrombocytopenia Purpura (TTP) is a rare disorder of the blood coagulation system.
-
UCLH Director of Research Professor Bryan Williams has been elected as the next President of the International Society of Hypertension (ISH).
-
COVID-19 vaccines are effective for most cancer patients but the level of protection offered by vaccines against infection, hospitalisation and death is lower compared with the general population and also wanes more quickly, according to a study in which UCLH participated.
-
A study at UCLH has found a combination treatment of immunotherapy with an experimental drug may reverse a cancer’s resistance to immunotherapy – making the cancer sensitive to treatment again.
-
UCLH doctor 1 of 10 international members elected to National Academy of Medicine
File results
-
FOI/2023/0948 - Inpatient wards and bed capacity
-
FOI/2023/0954 - Treatment of melanoma/ Renal cell carcinoma/ Oesophageal cancer
-
FOI/2023/0957 - Maternity services intervention statistics; still birth, elective C-section, emergency C-section
-
FOI/2023/0961 - Robotic Process Automation staff details
-
FOI/2024/0001 - Intrathecal therapy services/ spasticity service
-
FOI/2024/0003 - Translation, interpretation and language service costs - 2019/20 to 2022/2023
-
FOI/2024/0009 - Electronic Patient Record (EPR) and Medical Device Integration (MDI) solution
-
FOI/2024/0012 - Paediatric asthma wait time and referrals
-
FOI/2024/0013 - Medications within dermatology and respiratory medicine
-
FOI/2024/0017 - Assault attendances to Emergency Department 2023